top of page
gradientForSurfBreak.png

Item List

Newswires
xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

xCures, Inc. is proud to announce their partnership with RenovoRx, a clinical-stage biopharmaceutical company that focuses on fighting cancer through localized treatment of difficult-to-treat tumors, such as pancreatic adenocarcinoma. Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer (TIGeR-PaC).

Recent Posts

Portfolio Company

Carlsmed.png

Top 20 UK and EU Artificial Intelligence Startups To Look Out For in 2024 ...

TechRound

Portfolio Company

Carlsmed.png

Skin Analytics looks to remap patient pathways for cancer diagnoses ...

Digital Health

General News

Carlsmed.png

AdvaMed Praises Administration’s “Women’s Health Research” Initiative ...

AdvaMed

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page